Understanding Emerging Substances in Clinical Practice: Focused Insights on Cychlorphine, Kratom Alkaloids, and Phenazolam

Register for our Next Live Webinar Presentation

Understanding Emerging Substances in Clinical Practice: Focused Insights on Cychlorphine, Kratom Alkaloids, and Phenazolam

Date: Thursday, June 25, 2026 | Time: 9AM (CT) and 1PM (CT)

Please join us for an educational webinar on Thursday, June 25, 2026, hosted by Hope Randle, Pharm.D., BCPS, BCPP, Clinical Pharmacist, Aegis Sciences Corporation. Dr. Randle will discuss several emerging substances currently impacting clinical toxicology, including cychlorphine, mitragynine (kratom), and phenazolam. The session will review pharmacology, clinical effects, and potential risks associated with these compounds, with emphasis on trends in the evolving illicit drug supply. Attendees will also be introduced to educational and clinical support resources available through the Aegis Emerging Substances webpage and related provider education tools.

Objectives Include: 

• Describe the pharmacologic class, clinical effects, and potential toxicities associated with emerging substances including cychlorphine, kratom alkaloids, and phenazolam.
• Recognize current trends in the evolving illicit drug supply and identify challenges these substances present for clinical management, interpretation of toxicology results, and patient safety.
• Utilize educational and clinical resources available through Aegis Sciences Corporation’s Emerging Substances resources to support provider awareness, patient education, and informed clinical decision-making.